CapsoVision (CV) Exchange Rate Effect (2024 - 2025)
CapsoVision (CV) reported Exchange Rate Effect of $4000.0 for Q4 2025, up 104.88% on a YoY basis from $1952.4 in Q4 2024, and down 66.67% sequentially from $12000.0 in Q3 2025.
CapsoVision (CV) Exchange Rate Effect (2024 - 2025) Analysis & Trends
CapsoVision (CV) has 2 years of Exchange Rate Effect data on file, last reported at $4000.0 in Q4 2025.
- For the quarter ending Q4 2025, Exchange Rate Effect rose 104.88% year-over-year to $4000.0; the trailing twelve-month figure through Dec 2025 stood at -$27000.0 (changed N/A YoY), and the FY2025 full-year result was $143000.0, up 304.29% from the prior year.
- Exchange Rate Effect fell to $4000.0 in Q4 2025, from $12000.0 in the prior quarter.
- In the past five years, Exchange Rate Effect ranged from a high of $39000.0 in Q3 2024 to a low of -$82000.0 in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | -23.00 Mn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | -19.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 33.00 Mn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 8.20 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | -2.80 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 45.66 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | -37.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | CapsoVision | 162.07 Mn | 151.95 Mn | 1.95 Mn | 4,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 4,000.00 |
| Dec 31, 2025 | 4,000.00 |
| Sep 30, 2025 | 12,000.00 |
| Sep 30, 2025 | 12,000.00 |
| Dec 31, 2024 | -82,000.00 |
| Dec 31, 2024 | -82,000.00 |
| Sep 30, 2024 | 39,000.00 |
| Sep 30, 2024 | 39,000.00 |